clinical trial of Pippali Rasayana and Nagaradi Kashaya Ghana Vati combination as an adjuvant treatment with ICMR guided medicines in Covid-19 positive mildly symptomatic cases

INTERVENTION: Intervention1: Pippali Rasayana Nagradi Kashaya Ghana Vati and ICMR directed therapy : Pippali Rasayana‐ 2gm O.D. orally Rasayana Kala With Honey‐ 3gm Ghee‐ 5gm for 14 days Nagaradi Kashaya Ghana Vati‐ 500mg B.D orally Vyanodana Kala for 14 days Control Intervention1: ICMR directed treatment for Covid19 mildly symptomatic cases along with Pippali Rasayan and Nagaradi Kashay Ghana Vati: ICMR Directed therapy for covid 19 mildly symptomatic patients along with Pippali Rasayana and Nagaradi Kashay Ghana Vati in one group and only ICMR directed therapy in another group CONDITION: Health Condition 1: B972‐ Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B972‐ Coronavirus as the cause of diseases classified elsewhere PRIMARY OUTCOME: Covid‐19 positive mildly symptomatic patients will turn Covid negative after administration of combination of Pippali Rasayana +Nagaradi Kashaya Ghana Vati along with the ICMR guided treatment ; Recovery from the symptoms will be early and significant after administration of Pippali Rasayana +Nagaradi Kashaya Ghana Vati in mildly symptomatic Covid 19 positive patients ; ; Timepoint: Day 0 Day 14 ; SECONDARY OUTCOME: relief in associated symptoms if anyTimepoint: Day 0 Day 14 INCLUSION CRITERIA: 1 Patients with Covid ‐19 test positive (Confirmed using RT‐PCR test) 2 Covid‐19 positive patients willing to participate in the study. 3 Patients of either sex having age above 20 yrs. below 70 yrs. 4 Covid‐19 positive mildly symptomatic